Lv1
40 积分 2024-08-21 加入
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan
2个月前
已完结
Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications
4个月前
已完结
Combination strategy of CD16-engineered bispecific CAR-NK to enhance antitumor effects in ovarian cancer model
5个月前
已关闭
Anti-HER2×CCR4 bispecific antibody enhances antitumor immunity in advanced HER2-positive tumors by chemotaxis blockade and depletion of tumor-associated Tregs, without inducing systemic toxicity
7个月前
已关闭
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy
7个月前
已完结
Anti‐tumor effect of SLPI on mammary but not colon tumor growth
7个月前
已完结
Anti‐tumor effect of SLPI on mammary but not colon tumor growth
7个月前
已完结
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
8个月前
已完结
皖公网安备34019202002308
